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Summary: Hemolymphangiomatosis is an extremely rare entity
that has never been described in the diffuse form. Its main pathologic
feature is proliferation of lymphatic and vascular cells inducing inter-
stitial and hematic lakes and then splenomegaly. We report a complete
imaging study, including magnetic resonance (MR) imaging, after
administration of a superparamagnetic contrast agent. Ultrasonogra-
phy (US), basal MR imaging, and late computed tomography (CT)
contrastographic features are quite similar to those of other diffuse
benign vascular neoplasms, without real hemangioma-like enhance-
ment during the vascular phase. Its late contrastographic pattern could
be considered specific if CT and iron oxide–enhanced MR imaging
are applied as complementary diagnostic tools, however.
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Hemolymphangioma is a tumor characterized by prolifer-ation of lymphatic and vascular cells. Such neoplasms
can be localized in the orbit, tongue, neck, mediastinum, or
abdomen. Splenic localization is rare, however, and its imag-
ing has been reported only some decades ago;1,2 features of
the diffuse form were never described. We describe a case of
hemolymphangiomatosis, which was also analyzed at magnetic
resonance (MR) imaging after administration of a superpar-
amagnetic contrast agent, otherwise rarely used in the study of
splenic pathologic findings.3
Iron oxide contrast agent, when hydrated, has a strong
T1 relaxation property, allowing enhancement of the vessels,
and thus of angiomas. Its small particles are phagocytosed by
the cells of the reticuloendothelial system. This offers the
possibility to distinguish malignant tissues, in which there are
no phagocytic Kupffer cells and, consequently, no signal in-
tensity (SI) change, from normal tissue and benign tumors, in
which there is SI loss in T2-weighted images.4
CASE REPORT
A 38-year-old woman in excellent physical condition was
referred to a hematologist for asymptomatic moderately ingravescent
thrombocytopenia (platelet count = 102,000 cells/mm3). The patient’s
medical history was negative, except for a surgical intervention in
childhood for unclarified angioma of the thymus. The patient had
2 uncomplicated pregnancies. Physical examination revealed only huge
splenomegaly. Antiplatelet antibodies were absent, and the results of
peripheral blood tests were negative. Bone marrow biopsy and aspira-
tion indicated normal hemopoiesis with stimulated megakaryocytes.
Cardiac ultrasonography (US) and electrocardiography revealed a
marked axial cardiac deviation. Transabdominal US, performed with
an Astro MP (Esa Ote-Ansaldo, Genoa, Italy) with a 3.5-MHz convex
probe, confirmed inhomogeneous splenomegaly (Fig. 1A). A spiral
computed tomography (CT) examination was performed using a
Somatom Plus (Siemens, Erlangen, Germany) single-row scanner.
After a direct scan and intravenous administration of 100 mL iodin-
ated contrast agent (Ultravist 370; Schering, Berlin, Germany) at rate
of 3 mL/s, 4 acquisitions were obtained (8-mm thickness, pitch = 1).
Computed tomography further confirmed splenomegaly (diameter of
24 cm) with inhomogeneous density attributable to multiple hypodense
masses (diameters from 1 mm to 4–5 cm), more evident at the arterial
(see Fig. 1B), portal venous, and equilibrium phases because of en-
hancement of the surrounding parenchyma. At the 60-minute scan
performed to demonstrate possible delayed enhancement of the lacu-
nae, the resultant spleen density was quite homogeneous for slow
enhancement of the masses (see Fig. 1C).
The patient underwent an MR imaging examination on a 1.5-T
unit (Gyroscan ACS NT; Philips, Eindhoven, The Netherlands) with
a body phased-array coil. Direct axial breath-hold, fast field echo,
T1-weighted (repetition time = 110 milliseconds, echo time = 1.8
milliseconds, flip angle = 80, 7-mm slice thickness) and respiratory-
gated free-breath, turbo spin echo, single-shot, T2-weighted (repeti-
tion time = 810–870 milliseconds, echo time = 80–210 milliseconds,
turbo factor of 91–97, 4-mm slice thickness) sequences were per-
formed; T2 sequences were also acquired with fat suppression.
T1-weighted sequences were repeated 25, 70, and 180 seconds after
administration of 1.4 mL Resovist (SHU-555 A; Schering), followed
by a 20-mL saline solution flush; T1- and T2-weighted sequences
were performed again after 10 and 60 minutes. In direct T2-weighted
images (see Fig. 1F), the spleen appeared hyperintense because of the
presence of multiple coalescent masses, whereas the T1-weighted
scan showed only inhomogeneous SI without well-defined nodules.
The early contrast-enhanced T1-weighted images (see Fig. 1D)
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showed a pattern similar to that described at CT examination. Con-
versely, 10- and 60-minute T1-weighted images (see Fig. 1E) showed
only minimum enhancement, whereas T2-weighted scans (see Fig. 1G)
demonstrated no SI loss of lesions, which appeared hyperintense
and surrounded by a thin layer of markedly hypointense enhanced
parenchyma.
The 1600-g laparoscopically resected spleen had an even
surface (Fig. 2A) and contained several lacunae containing hematic or
serous liquid (see Figs. 2B, C); the latter were larger and more numer-
ous (approximately 60%–70%) than the former. Microscopically,
lacunae walls were lined by flat (and sometimes cuboid) endothelial
cells, which were anti-CD34 antibody- and anti-Factor VIII positive
and anti-pancytokeratin AE1/AE3 antibody-negative. The cells
detected in the lumen of the lacunae and in the intervessel spaces
were histiocytes (anti-CD68 antibody-positive) with increased iron
deposits (Perls positive). Small residues of normal spleen tissue were
still identifiable.
Evaluation of the sample and the anamnestic data on the child-
hood angioma directed us to the diagnosis of hemolymphangioma-
tosis of the spleen, associated with previous hemolymphangiomatosis
of the thymus. The spleen angioma, although probably present for
many years or even since birth, had undergone rapid enlargement.
Indeed, at US for pregnancy follow-up, performed 4 years before the
current diagnosis, no pathologic findings were evident.
DISCUSSION
In our reported case, the spleen, removed to prevent the
onset of hypersplenism and further enlargement, showed altered
architecture attributable to the presence of multiple cavities in
a limited residual normal parenchyma. Lacunae contained blood
or pink proteinaceous material conferring a ‘‘spongy’’ appear-
ance to the spleen (see Figs. 2B, C). Macroscopic and histologic
FIGURE 1. Imaging findings of a 38-year-old woman with splenomegaly. (A), Sonogram shows mottled echo texture of the spleen.
Early contrast-enhanced CT scan (B) shows an enlarged spleen containing innumerable, focal, low-density lesions with almost
homogeneous fill-in on a 60-minute contrast-enhanced CT scan (C). Early contrast-enhanced MR imaging T1-weighted image (D)
shows an enlarged spleen containing innumerable, focal, low-intensity lesions without significant fill-in on a 60-minute contrast-
enhanced MR imaging T1-weighted scan (E). T2-weighted precontrast image (F) shows innumerable, focal, hyperintense lesions
with no loss of SI after Resovist administration on a 60-minute T2-weighted image (G); such focal areas are better defined because
of negative enhancement of the surrounding parenchyma.
FIGURE 2. Pathologic findings of a 38-year-old woman with splenic lesions. A, Photograph of the surgically removed enlarged
spleen shows a deformed and markedly nodular exterior surface. B, Photograph of the cut surface demonstrates round dark areas
attributable to lakes filled with serous liquid. C, Photomicrograph (hematoxylin–eosin stain) of the histologic specimen shows
vascular lacunae containing blood and interstitial lakes filled with serous liquid (*).
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findings were consistent with US, CT, and basal MR imaging:
multiple sharply defined nodular areas, low SI on T1-weighted
images (see Fig. 1D) and high SI on strongly T2-weighted
images (see Fig. 1F), and homogeneous enhancement on the
CT scan at 60 minutes (see Fig. 1C).
Vascular neoplasms are the most common primary
tumors of the spleen and represent most nonlymphoid splenic
tumors. Of these, 2 are the most common: lymphangiomatosis
and hemangiomatosis. Lymphangiomatosis is usually composed
of endothelium-lined cystic avascular spaces containing eo-
sinophilic homogeneous material, which confer a characteristic
‘‘Swiss cheese’’ US and CT appearance to the spleen with
liquid SI at MR imaging.5 Hemangiomatosis presents an MR
imaging and US appearance similar to that of liver heman-
giomas: round, low-T1, and high-T2 masses; echogenic; and
occasionally with hypoanechoic vascular lacunae (cavernous
forms) or echoic areas (hemorrhagic foci). On CT scans, mul-
tiple, usually homogeneous, lesions are demonstrated. These
lesions are hypodensewith peripheral contrastographic enhance-
ment (‘‘fill-in’’) and are sometimes hyperdense compared with
surrounding normal parenchyma in the late phase.6
A similar contrastographic pattern is found in 2 other
types of splenic diffuse vascular neoplasms: littoral cell angi-
oma and hemangioendothelioma. The former is characterized
by a specific immunohistochemical phenotype and is composed
of anastomosing vascular channels resembling splenic sinuses.
Ultrasonography shows a diffuse heterogeneous echo texture
of the spleen. On CT, the usual contrastographic pattern of
hemangiomas can be demonstrated. Hemangioendothelioma is
an intermediate type of vascular endothelial neoplasm, thought
to be potentially more aggressive than hemangioma but still
not full-fledged angiosarcoma. The US appearance is variable,
and the contrastographic pattern may be similar to that of
benign forms.7 Both types may have T1/T2 hypointense areas
because of the presence of hemosiderin.8 Other vascular neo-
plasms such as hamartomas, hemangiopericytomas, and angi-
osarcomas have a variable nonpathognomonic US/MR imaging
appearance; in contrast to benign types, they show inhomo-
geneous enhancement during late-phase CT.Moreover, heman-
giopericytoma shows intense enhancement of its solid portions,
whereas angiosarcoma usually includes areas of necrosis, has
extra-splenic tumor extension, and exhuberates from spleen.
Malignancy and phlogosis usually show different radio-
logic patterns.7 In particular, with the exception of diffuse
infiltration of lymphoma, in both cases, there is no homoge-
neous enhancement during late-phase CT; therefore, such diag-
nostic hypotheses were not formulated after imaging.
The case described here presents some of the character-
istics of angiomas (high SI on T2-weighted images and late
homogeneous enhancement) but not the typical marked cen-
tripetal enhancement typical of liver hemangiomas.9 Moreover,
late-phase images showed only minimum T1 enhancement (see
Fig. 1E) without any T2 signal loss (see Fig. 1G).
A possible explanation for this late contrastographic pat-
tern may be related to the molecular dimensions and kinetics
of iodinated and iron oxide contrast agent (1.5 vs. 62 nm). On
CT, by 1 hour, the iodinated contrast could be equilibrated
through the extracellular fluid compartment (see Fig. 1C),
including the serous liquid lakes, which were apparently not in
connection with the vascular system and did not contain phago-
cytic cells. Conversely, Resovist, whose uptake is exclusively
by phagocytosis, did not leave the vascular compartment and
provoked scarce enhancement of vessels and hematic lacunae
on T1-weighted images, was not equilibrated through the ex-
tracellular fluid compartment (see Fig. 1E), and did not dem-
onstrate any negative enhancement of interstitial lakes on T2
images (see Fig. 1G).
In conclusion, splenic hemolymphangiomatosis is an
extremely rare entity whose US, basal MR imaging, and late
CT contrastographic features are quite similar to those of other
diffuse benign vascular neoplasms described previously, with-
out real hemangioma-like enhancement during the vascular
phase. Its late contrastographic pattern could be considered
specific if CT and iron oxide–enhanced MR imaging are
applied as complementary diagnostic tools.
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